(Date:12/2/2009).../PRNewswire-Asia/ -- Simcere Pharmaceutical Group,...ding pharmaceutical company,specializing in the de...,generic and proprietary pharmaceuticals in China,...ncluded in China,s National Drug Reimbursement Lis...f Human Resources and Social,Security on November ...
(Date:12/2/2009)...swire-Asia/ -- The world is going through,extraord...y is part of many,businesses and industries. It tu...ly immune to the economic downturn, because illnes...idst of the difficult times this year, the pharmac... R&D center in Shanghai, the largest of,its ki...
(Date:12/2/2009)...wire/ -- According to the National Institute of He...sed with diabetes already have some stage of diabe...the retina caused by leaky blood vessels, is a maj...is one of the most feared diabetic complications. ...had diabetes for 10 years or more will experience ...
(Date:12/1/2009)...PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL)... for the fourth quarter ended December 31, 2009 of...illion for the fourth quarter of 2008. Included in...installment payments of $12.5 million from Alexion...s a one-time $1.8 million payment from Genentech f...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3...s., Sept. 19 Inverness Medical,Innovations, Inc. ... of rapid,diagnostic products for the consumer and...anziger, Chairman, Chief Executive Officer and,Pre...are scheduled to,attend the UBS Global Life Scienc...he Grand Hyatt New York in New York City. The Comp...
...ss., Sept. 19 PLC Systems Inc.,(Amex: PLC ) toda...re to,meet listing qualifications dated September ...t staff at the American Stock Exchange. The notice...h Section 1003(a)(ii) of,the AMEX Company Guide be...than $4,000,000 as of June 30, 2008, and it incurr...
...a, Sept. 19 /Xinhua-PRNewswire-FirstCall/ -- China... "the Company") (Nasdaq: CSKI ), a,leading fully ...he-counter,drugs in the People,s Republic of China... completed the first phase of examinations for the...ark, which indicates that,a company,s products hav...
Other Biology Technology:PLC Systems Receives Delisting Notice From American Stock Exchange 2China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification 2China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification 3Beagle Serum from Innovative Research
Mouse Anti-Human MBP aa67-74 Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Bovine TROPONIN I (CARDIAC & SKELETAL) Monoclonal Antibody, Unconjugated, Clone C5 from AbD Serotec
X-Gal/IPTG Solution from Bioline
Biology Products: